Inner Light Care

A treatment we offer · For substance use disorders

Addiction medicine

Evidence-based care for opioid and alcohol use, alongside the psychiatric care you may also need. We use long-acting injectable medications, oral options, and A point-of-care urine test done in the office that gives results in minutes — used to support your recovery, not surveil you. — all without judgment, and at the pace that fits your life.

How we approach this

Substance use disorders are treatable medical conditions — not moral failings. Our job is to help you find a path forward that works for your body, your schedule, and your life. That usually means medication, counseling referrals, and the steady accountability of a clinician who actually knows you.

We use the term MOUD: Medications for Opioid Use Disorder. Often replaces the older term 'MAT' (medication-assisted treatment), which framed medication as an add-on rather than a primary treatment. — medications for opioid use disorder — because the research is clear that these medications are primary treatment, not optional. We meet you where you are: whether that’s your first conversation about cutting back, or your tenth attempt at maintenance.

SAMHSA National Helpline: 1-800-662-HELP (4357) is free, confidential, and open 24/7 — in English and Spanish — for information and treatment referrals. A good first call if you’re not sure what kind of help you need, or if you’d like to talk to someone tonight.

Medications we offer

No single medication is right for everyone. We’ll talk through what fits your goals, your history, and the practical realities of your week.

Long-acting injectable medications — given here in the office, eliminating daily dosing:

  • Sublocade — a Buprenorphine: a partial opioid agonist that relieves withdrawal and cravings without producing the full opioid high. Schedule III. injection given under the skin of the abdomen, once a month. For moderate-to-severe opioid use disorder.
  • Brixadi — also a buprenorphine injection, but available as either a weekly or monthly dose, with more injection-site options. The weekly form can be helpful early in treatment when doses still need fine-tuning.
  • Vivitrol — a Naltrexone: an opioid antagonist that blocks opioid receptors, so opioids don't produce a high. For alcohol use, it reduces cravings. injection given in the muscle, once a month. FDA-approved for both alcohol use disorder and prevention of return to opioid use after detox. Not a controlled substance. For Vivitrol to be safe, you’ll need to be opioid-free for 7–10 days first — otherwise the medication can trigger sudden, severe withdrawal. We’ll plan that bridge together so the transition is as comfortable as possible.
A note on location: Sublocade and Brixadi are given through a federally-required REMS program at REMS-certified offices. Today that’s our New Jersey location — Utah REMS certification is in progress. Vivitrol and the oral options below aren’t subject to REMS and can happen at either office.

Oral options — for stabilization, ongoing care, or when an injection isn’t the right fit:

  • Sublingual buprenorphine (Suboxone, Zubsolv, generics) — first-line for opioid use disorder; relieves withdrawal and cravings.
  • Naltrexone (oral) — a daily option for alcohol use disorder.
  • Acamprosate and disulfiram — additional options for alcohol use disorder that work in different ways than naltrexone.
  • Comfort medications for withdrawal — clonidine, lofexidine, gabapentin, and others, used short-term to ease the physical symptoms of stopping.
A note on methadone: methadone for opioid use disorder is only available through federally certified Opioid Treatment Programs and can’t be prescribed from a private practice. If that’s the right fit for you, we’ll help connect you to a program that can support it.

If you’re pregnant or thinking about becoming pregnant

If pregnancy is a possibility, the medication conversation looks a little different — and we’ll have it together, openly. Buprenorphine and methadone remain the two first-line treatments recommended by American College of Obstetricians and Gynecologists. for opioid use disorder during pregnancy.

Among the long-acting injectable options, the weekly form of Brixadi is the only formulation studied in pregnant patients (under the FDA’s Medication treatment for Opioid use disorder in expectant Mothers — an FDA-supervised study of weekly extended-release buprenorphine in pregnancy. study) because, unlike Sublocade and monthly Brixadi, it doesn’t contain the N-methyl-2-pyrrolidone — a solvent used in monthly extended-release buprenorphine products. Animal studies have raised fetal-development concerns, which is why the NMP-containing formulations are not currently used in pregnancy. solvent that animal studies have flagged as a fetal concern. Daily sublingual buprenorphine is also a well-established option throughout pregnancy.

How we work with pregnancy — perinatal opioid-use-disorder care works best as a coordinated team, and we don’t run a perinatal addiction program in-house. When pregnancy is a factor, we’ll help you find a specialty program with the right OB and addiction-medicine integration for where you live, and (with your permission) stay in touch with your team so the pieces of your care talk to each other.

On-site urine testing

We offer point-of-care urine drug screening here in the office, with results available in minutes rather than days. This isn’t about surveillance — it’s a clinical tool that helps us see how a medication is working, catch a return to use early, and adjust the plan together. Real-time results mean we can have a real-time conversation, not a delayed phone call.

When something unexpected shows up on a screen, we send a confirmation sample to the lab and talk it through openly. Returning to use is part of many recoveries; it’s information, not failure.

Who this is for

Adults thinking about, starting, or continuing treatment for an opioid or alcohol use disorder — whether you’re new to this or have been working on it for years. We can also coordinate care if you’re already established with a counselor, sponsor, or program and just need a prescriber who listens.

If you also live with depression, anxiety, ADHD, or another psychiatric condition — which is true for most people we see — we treat those alongside, not separately. The integration is the point.

About visit format — follow-up visits and oral-medication management can often happen by telehealth. Telehealth visits are only available when you’re physically located in New Jersey or Utah at the time of the visit; if you’ll be traveling, let us know so we can reschedule. Sublocade and Brixadi injections happen in person at our New Jersey office under REMS monitoring.
Vanessa is an associate member of ASAM (the American Society of Addiction Medicine) and stays current with addiction-medicine practice through ongoing education with NEI (the Neuroscience Education Institute).

About this page

This page describes treatments we offer; it is not medical advice for any individual. Whether one of these medications is right for you depends on your medical history and current health, which we will review together at your visit.

Next step

Ready when you are.

Book a visit to walk through your history together — what you've tried, what's worked, what hasn't — and whether one of these treatments could be part of a plan that fits your life. No pressure. No judgment.